iNOS is a key mediator of anti-PD-1 melanoma therapy response - Poll - MDSpire

iNOS is a key mediator of anti-PD-1 melanoma therapy response

  • By

  • Quang Tam Nguyen

  • Youngchul Kim

  • Thi Hong Nga Le

  • Saurabh Garg

  • Vishanna Balkaran

  • Trisha Bhathivi

  • Alejandra Chamizo

  • Christopher W. Dukes

  • Kimberly Ward

  • Andrew S. Brohl

  • Lilit Karapetyan

  • Nikhil I. Khushalani

  • Zeynep Eroglu

  • Ahmad A. Tarhini

  • James J. Mulé

  • Joseph Markowitz

  • June 22, 2026

  • 0 min

Share

Original Source(s)

iNOS is a key mediator of anti-PD-1 melanoma therapy response

  • by Quang Tam Nguyen, Youngchul Kim, Thi Hong Nga Le, Saurabh Garg, Vishanna Balkaran, Trisha Bhathivi, Alejandra Chamizo, Christopher W. Dukes, Kimberly Ward, Andrew S. Brohl, Lilit Karapetyan, Nikhil I. Khushalani, Zeynep Eroglu, Ahmad A. Tarhini, James J. Mulé, Joseph Markowitz

  • June 22, 2026

Related Content

Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Spatial RNA velocity reveals cellular state transitions and prognostic markers in the melanoma microenvironment